Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
International Breast Cancer Study Group
InstitutionResearch output, impact & collaborations
International Breast Cancer Study Group is a research organisation in Bern, CH. OpenAlex records 884 works and 257,054 citations for it. 223 researchers list it as their most recent affiliation.
884
Works
257,054
Citations
223
Researchers
85
Avg h-index
How has International Breast Cancer Study Group's publication output changed over time?
ScholarIQpublication output · 2014–2019
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2019.
1
1
1
201420182019
What are the most-cited papers on International Breast Cancer Study Group?
ScholarIQmost cited works
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jérusalem, Rupert Bartsch, Manuela Rabaglio, Roswitha Kammler, Rudolf Maibach, Mark J. Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M. Regan, Fabrice André, Debora Fumagalli, Richard D. Gelber, Theodora Goulioti, Anita Hiltbrunner, Rita L. Hui, Heidi Roschitzki, Barbara Ruepp, Frances M. Boyle, Rolf A. Stahel, Stefan Aebi, Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier
The Lancet Oncology. 2019481 Citations
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
K.M. Kerr, L. Bubendorf, Martin J. Edelman, Andrea Ascoli Marchetti, Tony Mok, Silvia Novello, Kenneth J. O’Byrne, Rolf A. Stahel, Solange Peters, Enriqueta Felip, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel
Annals of Oncology. 2014300 CitationsOPEN ACCESS
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
Solange Peters, Rolf A. Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M. Kowalski, Christina S. Baik, Dolores Isla, Javier de Castro, Pilar Garrido, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H. Lam, Michael W. Lu, Thomas E. Stinchcombe
Clinical Cancer Research. 2018231 CitationsOPEN ACCESS
How much of the research on International Breast Cancer Study Group is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
67%
Closed
33%